Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Xcyte Digital Corp. Releases "Xperience" Subscription Service (click to learn more)
Star Diamond: High Modelled Diamond Prices and High Proportions of Type IIa Diamonds (click to learn more)
Northstar Discovers Large Near Surface EM Conductor SE of Cam Copper Mine (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Acasti Pharma Inc
ACST
Healthcare
Acasti Pharma Inc. is a Canada-based late-stage biopharma company with drug candidates addressing rare and orphan diseases. The Company is targeting three underserved orphan diseases: GTX-104, an intravenous infusion targeting subarachnoid hemorrhage (SAH), a rare and life-threatening medical emergency, in which bleeding occurs over the surface of the brain in the subarachnoid space between the...
brain and skull; GTX-102, an oral mucosal spray targeting ataxia-telangiectasia (A-T), a progressive, neurodegenerative genetic disease that primarily impacts children causing severe disability; and GTX-101, a topical spray, targeting postherpetic neuralgia, a persistent and often debilitating neuropathic pain caused by nerve damage from the varicella zoster virus (shingles). The Company’s clinical assets have each been granted Orphan Drug Designation by the FDA, which provides seven years of marketing exclusivity post-launch in the United States, and additional intellectual property protection.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:ACST)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(13)
•••
Danny1082Man
X
View Profile
View Bullboard History
Comment by
Danny1082Man
on May 06, 2020 8:44pm
RE:news
The strongest thesis I hear as truth is the identified placebo group in those 5 sites were put on statins, have been identified and isolated in the briefing to the FDA. Now what to do with them is the
...more
(53)
•••
Canadian_101
X
View Profile
View Bullboard History
Post by
Canadian_101
on May 04, 2020 3:42pm
Bank of America Increases position In ACST by over 1800%
Nice to see that the institutions are buying, thats always a good sign (Posted mat 4ty 2020) Bank of America Corp DE boosted its position in shares of Acasti Pharma Inc (NASDAQ:ACST) by 1,862.0%
...more
GameSquare Announces Formation of FaZe Media, a Creator-led IP and Media Company, led by CEO FaZe Banks and Backed by $11 Million Investment from Matt Kalish
posted May 16, 2024 9:00am by
GameSquare Holdings Inc.
-
|
Justin Kenna, CEO of GameSquare stated, "Since completing the acquisition of FaZe Clan, we have focused on returning FaZe's founders to reboot their brand and reestablish its authenticity. We are thrilled to better capitalize this business for growth with $11 million in new capital from Matt, and to strengthen the FaZe Media board with his addition. Matt deeply believes in the power of founder and creator-led organizations and ...read more
(13)
•••
Danny1082Man
X
View Profile
View Bullboard History
Post by
Danny1082Man
on May 02, 2020 10:10pm
Post hoc analysis
They stepped in a hole with Trilogy 1. Without Trilogy 2 post hoc analysis is a worthless venture. However, Trilogy 2 is large enough to meet the primary endpoint on its own. And with analysis and
...more
(51)
•••
postie1
X
View Profile
View Bullboard History
Post by
postie1
on Apr 30, 2020 8:42pm
news
Acasti Pharma Announces Submission of TRILOGY 1 Briefing Package to FDA V.ACST | 12 hours ago FDA response expected on or before June 30, 2020
...more
(2)
•••
Super63
X
View Profile
View Bullboard History
Post by
Super63
on Apr 30, 2020 4:06pm
Hong Kong patent
Eddingpharm is based in Hong Kong. They are developing Vascepa there and paid a license fee for the priv. With today's patent award there for Capre the table is set in China. Am I right
...more
(77)
•••
Rosmorduc
X
View Profile
View Bullboard History
Post by
Rosmorduc
on Apr 30, 2020 9:53am
CAPRE will be essential for good health to combat Corona
Vaccines are bogus to combat Corona viruses. These viruses are to many and existing ones mutate every year rendering the vaccines semi-useless (work only 25% of the time and you have to take a
...more
(3)
•••
seanj1
X
View Profile
View Bullboard History
Comment by
seanj1
on Apr 28, 2020 3:00pm
RE:RE:Full Steam Ahead
The recent weakness is a good opportunity to add. This stock jumps fast with any good news. Capre is better than Vascepa and the recent anomaly in clinical trial will be cleared soon. Averege down
...more
(77)
•••
Rosmorduc
X
View Profile
View Bullboard History
Comment by
Rosmorduc
on Apr 28, 2020 12:43pm
RE:Full Steam Ahead
Yup. We're consolidating here forming a very nice technical cup handle which is bullish. The stock price (how it's trading) along with technicals and volume always tells you the story.
...more
(13)
•••
Danny1082Man
X
View Profile
View Bullboard History
Post by
Danny1082Man
on Apr 28, 2020 12:02pm
Full Steam Ahead
This has been debated to nausism. I don't care about those looking for insight, swinging in and out, of think this won't be a successful read out. If you don't believe move along. If your
...more
(77)
•••
Rosmorduc
X
View Profile
View Bullboard History
Comment by
Rosmorduc
on Apr 28, 2020 9:49am
RE:Anyone know
Who cares? This is the ACST board. CAPRE all the way.
(6)
•••
theblackestcat
X
View Profile
View Bullboard History
Comment by
theblackestcat
on Apr 28, 2020 8:43am
RE:RE:EPanova
insider selling
(3)
•••
boozehound3
X
View Profile
View Bullboard History
Comment by
boozehound3
on Apr 27, 2020 8:23pm
RE:RE:RE:RE:EPanova
Are you stupid?
(6)
•••
Piccolo31
X
View Profile
View Bullboard History
Comment by
Piccolo31
on Apr 27, 2020 7:32pm
RE:RE:RE:EPanova
can u elaborate more? Im not sure what you are trying to say?
(3)
•••
boozehound3
X
View Profile
View Bullboard History
Comment by
boozehound3
on Apr 27, 2020 7:28pm
RE:RE:EPanova
No. Insider trading Not buying
(6)
•••
Piccolo31
X
View Profile
View Bullboard History
Comment by
Piccolo31
on Apr 27, 2020 7:14pm
RE:EPanova
insider buying with acasti? Isnt that a good thing?
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition
GameSquare Announces Formation of FaZe Media, Backed by $11M Investment
IAMGOLD Reports First Quarter 2024 Results
Xcyte Digital Corp. Releases "Xperience" Subscription Service
Drilling Approval Received for New Mexico Lithium Project